Long-Term Dupilumab for AD Evaluated in Cohort Study ...Middle East

Dupilumab maintained its effectiveness in patients with atopic dermatitis for up to 5 years, with adverse events and ineffectiveness being the primary reasons for discontinuation, in a cohort study reflecting daily practice. Medscape Medical News

Hence then, the article about long term dupilumab for ad evaluated in cohort study was published today ( Thursday 08/08/2024 - 12:00 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Long-Term Dupilumab for AD Evaluated in Cohort Study )

Also on site :

• Rooster Runs Wild: Director Zach Braff Breaks Down Greg's Night Out In Episode 4 — And Working With John C. McGinley Across Two Shows
• China conducts patrols in disputed area of ​​the South China Sea
• Walmart's 'Super Bright' $29 Motion-Activated Solar Lights Set Is a 'Breeze to Install'